108 related articles for article (PubMed ID: 22500505)
1. [Routine follow-up in patients treated of head and neck cancer].
Wierzbicka M; Waśniewska E; Jackowska J; Leszczyńska M; Szyfter W
Otolaryngol Pol; 2012; 66(2):138-47. PubMed ID: 22500505
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of current regular follow-up policy after treatment for head and neck cancer: Need for individualized and obligatory follow-up strategy.
Jung YH; Song CM; Park JH; Kim H; Cha W; Hah JH; Kwon TK; Kim KH; Sung MW
Head Neck; 2014 May; 36(5):715-21. PubMed ID: 23616261
[TBL] [Abstract][Full Text] [Related]
3. The value of routine follow-up after treatment for head and neck cancer. A national survey from DAHANCA.
Pagh A; Vedtofte T; Lynggaard CD; Rubek N; Lonka M; Johansen J; Andersen E; Kristensen CA; von Buchwald C; Andersen M; Godballe C; Overgaard J; Grau C
Acta Oncol; 2013 Feb; 52(2):277-84. PubMed ID: 23320772
[TBL] [Abstract][Full Text] [Related]
4. The value of periodic follow-up in the detection of recurrences after radical treatment in locally advanced head and neck cancer.
Flynn CJ; Khaouam N; Gardner S; Higgins K; Enepekides D; Balogh J; MacKenzie R; Singh S; Davidson J; Poon I
Clin Oncol (R Coll Radiol); 2010 Dec; 22(10):868-73. PubMed ID: 20650620
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound in patients with treated head and neck carcinomas: A retrospective analysis for effectiveness of follow-up care.
Jiang H; Tan Q; He F; Yang W; Liu J; Zhou F; Zhang M
Medicine (Baltimore); 2021 Apr; 100(16):e25496. PubMed ID: 33879682
[TBL] [Abstract][Full Text] [Related]
6. The follow-up of patients with head and neck cancer: an analysis of 1,039 patients.
Kothari P; Trinidade A; Hewitt RJD; Singh A; O'Flynn P
Eur Arch Otorhinolaryngol; 2011 Aug; 268(8):1191-1200. PubMed ID: 21193920
[TBL] [Abstract][Full Text] [Related]
7. [Prophylactic medical examination of patients with head and neck tumours in Moscow--continuity of patients' care provided by oncologists and general practitioners].
Sdvizhkov AM; Shatskaia NKh; Kuznetsov IL
Vestn Otorinolaringol; 2010; (2):21-3. PubMed ID: 20517274
[TBL] [Abstract][Full Text] [Related]
8. 'When will I see you again?' Using local recurrence data to develop a regimen for routine surveillance in post-treatment head and neck cancer patients.
Lester SE; Wight RG
Clin Otolaryngol; 2009 Dec; 34(6):546-51. PubMed ID: 20070764
[TBL] [Abstract][Full Text] [Related]
9. A longitudinal study of follow-up activities after curative treatment for head and neck cancer.
Pagh A; Grau C; Overgaard J
Acta Oncol; 2015 May; 54(5):813-9. PubMed ID: 25907822
[TBL] [Abstract][Full Text] [Related]
10. Importance of treatment institution in head and neck cancer radiotherapy.
Kubicek GJ; Wang F; Reddy E; Shnayder Y; Cabrera CE; Girod DA
Otolaryngol Head Neck Surg; 2009 Aug; 141(2):172-6. PubMed ID: 19643247
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of frequency and treatment showed of head and neck cancers in ENT].
Lenecki A
Otolaryngol Pol; 2004; 58(2):385-7. PubMed ID: 15307489
[No Abstract] [Full Text] [Related]
12. [Responsibilities of the otorhinolaryngologist in the follow-up of malignancies of the head and neck].
Tesche S; Metternich FU
HNO; 2006 Sep; 54(9):721-6; quiz 727-8. PubMed ID: 16705350
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of routine follow-up of patients treated for T1-2N0 oral squamous cell carcinomas of the floor of mouth and tongue.
Merkx MA; van Gulick JJ; Marres HA; Kaanders JH; Bruaset I; Verbeek A; de Wilde PC
Head Neck; 2006 Jan; 28(1):1-7. PubMed ID: 16155911
[TBL] [Abstract][Full Text] [Related]
14. [Advances in the diagnosis of unknown primary carcinoma of the neck].
Kruk-Zagajewska A; Milecki P; Wierzbicka M
Otolaryngol Pol; 2005; 59(1):77-83. PubMed ID: 15915923
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen].
Arlt A; Luckhaupt H; Hildmann H
Laryngorhinootologie; 2000 Apr; 79(4):207-12. PubMed ID: 10838684
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment screening on distant metastases and head and neck cancer patients: Validation of risk factors and influence on survival.
Peters TT; Senft A; Hoekstra OS; Castelijns JA; Witte BI; Leemans CR; de Bree R
Oral Oncol; 2015 Mar; 51(3):267-71. PubMed ID: 25552384
[TBL] [Abstract][Full Text] [Related]
17. Value of routine follow-up in patients treated for squamous cell carcinoma of the head and neck.
Boysen M; Natvig K; Winther FO; Tausjö J
J Otolaryngol; 1985 Aug; 14(4):211-4. PubMed ID: 4057330
[TBL] [Abstract][Full Text] [Related]
18. [Centralized follow-up of patients treated for head and neck cancer].
Grau C; Specht LK; Hansen HS; Overgaard M; Overgaard J
Ugeskr Laeger; 1997 Feb; 159(8):1104-8. PubMed ID: 9072857
[TBL] [Abstract][Full Text] [Related]
19. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.
Tiwana MS; Hay J; Wu J; Wong F; Cheung W; Olson RA
Laryngoscope; 2014 Oct; 124(10):2287-91. PubMed ID: 24729185
[TBL] [Abstract][Full Text] [Related]
20. Soft tissues sarcomas of the head and neck in adult: histo-clinical analysis of 30-years material in the data of ENT Department of Silesian Medical University.
Markowski J; Dziubdziela W; Podlejska K; Likus W; Pasternak K; Kajor M; Witkowska M; Gierek T; Paluch J
Otolaryngol Pol; 2012; 66(6):382-6. PubMed ID: 23200557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
